People on the Move: Robert Lalley, MBA, Director of Gene Therapy Procurement – Site Head, Catalent Pharma Solutions
Catalent Pharma Solutions elevates its gene therapy capabilities with the appointment of Robert Lalley, MBA, as Director of Gene Therapy Procurement – Site Head. Bringing a wealth of experience in strategic sourcing and external manufacturing for advanced cell and gene therapies, Robert is set to lead transformative initiatives at Catalent’s BWI site.
November 6, 2024
| BioBuzz’s mission is simple: to be more connected. Our regionally-focused storytelling, programs, events and experiences connect, amplify and create impact across the life science workforce in growing biohubs. Submit your People On The Move (free and ongoing) to showcase your company’s growth by promoting your new hires and recent promotions. |
Catalent Pharma Solutions, a global leader in pharmaceutical, biotech, and consumer health product development, has named Robert Lalley as Director of Gene Therapy Procurement. With a wealth of strategic sourcing expertise and over a decade of leadership experience from his tenure at Vertex Pharmaceuticals and Emergent BioSolutions, Lalley will spearhead Catalent’s efforts in gene therapy, an area of explosive growth and innovation.
In his new role, Lalley will be instrumental in optimizing Catalent’s supply chain for its Biologics and Cell & Gene Therapy (BWI) division. His responsibilities include ensuring the efficient sourcing of biologic raw materials, strengthening partnerships with contract development and manufacturing organizations (CDMOs), and managing cell banking to meet the increasing demand for gene therapies. His focus will be on aligning Catalent’s procurement capabilities with the company’s growing portfolio of advanced therapies, enabling faster, more reliable delivery of cutting-edge treatments to patients worldwide.
Lalley’s strategic leadership comes at a critical juncture for Catalent, as the company is rapidly expanding its capabilities in gene therapy and personalized medicine. His expertise in supply chain optimization and external manufacturing partnerships will play a crucial role in scaling Catalent’s gene therapy pipeline.
About Robert Lalley
Robert Lalley is a seasoned expert in strategic sourcing and procurement, particularly within the cell and gene therapy sectors. Before his prestigious appointment as Director of Gene Therapy Procurement at Catalent Pharma Solutions, he served as Associate Director of Cell and Gene Therapy Strategic Sourcing at Vertex Pharmaceuticals, where he significantly advanced external manufacturing and supplier relationship management for therapies targeting cystic fibrosis, sickle cell disease, and Type 1 diabetes.
His career highlights include leading Biologic Raw Materials and Devices categories at Emergent BioSolutions during the COVID-19 pandemic, optimizing procurement strategies at AstraZeneca, and focusing on research procurement at Merck. Lalley holds an MBA from West Virginia University and has participated in international study programs in China and Italy. His expertise and leadership position him as a key player in driving innovation in the life sciences sector.
About Catalent Pharma Solutions
Catalent Pharma Solutions is a global leader in advanced delivery technologies and manufacturing solutions for drugs, biologics, and consumer health products. With over 1,000 products in development and partnerships with companies of all sizes, Catalent enhances patient outcomes and accelerates drug development.
Specializing in gene and cell therapy, Catalent has created over 70 billion doses, launched more than 160 dose forms annually, and is involved in 1,400 active development programs, contributing to 50% of FDA approvals in the last decade.
Headquartered in Somerset, New Jersey, and with facilities across four continents, Catalent is committed to delivering “More products. Better treatments. Reliably Supplied.™”
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
